Levelina

Bifonazole, the active ingredient in Levelina, is an imidazole antifungal presented as a topical formulation for skin application. It is used to treat superficial fungal infections such as athlete’s foot, ringworm and yeast infections of the skin, providing localized antifungal activity. It is indicated for use in adults and children when appropriate, and is applied directly to the affected area.

GNH USA supplies Levelina as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance and reliable logistics for global distribution.

Bifonazole is employed in the treatment of fungal skin infections by targeting the dermatophyte and yeast pathways. - Tinea corporis (ringworm of the body): reduces fungal growth, relieves redness and itching, and clears lesions. - Tinea pedis (athlete’s foot): alleviates itching, eliminates the causative dermatophytes, and promotes healing of the foot skin. - Tinea cruris (jock itch): controls infection, reduces irritation, and supports restoration of normal skin appearance. - Cutaneous candidiasis: eradicates Candida species from affected skin areas, relieving discomfort and preventing spread.

Topical application of bifonazole may be associated with local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Burning sensation: transient feeling of heat at the application site. - Pruritus: mild itching that usually resolves with continued use. - Erythema: redness of the skin where the product is applied. - Scaling: flaking of the treated skin. - Dryness: reduced skin moisture at the site.

Serious or Rare Side Effects: - Contact dermatitis: allergic skin reaction requiring discontinuation. - Stevens‑Johnson syndrome: severe mucocutaneous eruption, a medical emergency. - Systemic hypersensitivity: rare generalized rash or fever.

When using bifonazole topical products, certain precautions should be observed to ensure safety and effectiveness. - Avoid application on broken skin: do not apply to open wounds or severe abrasions. - Limit use to the affected area: spread only on infected skin to reduce irritation. - Monitor for allergic reactions: discontinue if signs of rash, swelling or severe itching develop. - Use with caution in children: follow pediatric guidance and avoid excessive quantities. - Store at room temperature: keep the product in the original container, protect from light and moisture.

Bifonazole may interact with other topical agents or systemic medications that affect fungal metabolism.

Major Interactions (Avoid): - Concurrent use with other imidazole or azole antifungals: may increase local toxicity. - Combination with potent CYP450 inhibitors applied to large skin areas: risk of systemic absorption and enzyme inhibition.

Moderate Interactions (Monitor Closely): - Co‑application with corticosteroid creams: may mask infection signs, requiring careful monitoring. - Use with occlusive dressings: enhances drug penetration and could increase irritation.